Reports Q4 revenue $47.54M, consensus $45.29M. “2024 was a terrific year for Geron (GERN) and for RYTELO, our first-in-class telomerase inhibitor, which we believe represents a highly ...

The Healey administration hopes to save residents billions of dollars in energy costs over the next five years by pulling a host of executive-branch levers, including redirection of some clean ...